Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://journals.lww.com/co-hematology/abstract/2007/11000/novel_therapies_in_myeloma.2.aspx, but it redirected us to https://journals.lww.com/co-hematology/abstract/2007/11000/novel_therapies_in_myeloma.2.aspx. The analysis below is for the second page.

Title[redir]:
Current Opinion in Hematology
Description:
cussed. Recent findings The immunomodulatory drugs, thalidomide and lenalidomide, and the proteasome inhibitor, bortezomib, have been shown to be effective agents, both alone and as part of combination regimens, for the treatment of myeloma. Studies are now focusing on the optimal sequencing of these drugs throughout the disease course, with a view to maximizing antitumor efficacy and minimizing overlapping toxicities. New protocols are increasingly based on preclinical evidence of synergy. The incorporation of these agents into transplant-based treatment protocols has improved outcomes. Other examples of novel agents undergoing assessment at present include arsenic trioxide, hsp90 inhibitors and histone deacetylase inhibitors. Future developments are likely to include individualized treatment plans based on patient-specific parameters including cytogenetic analysis and gene expression profiling. Summary Thalidomide, lenalidomide and bortezomib can now be considered as standard options both as first-line agents and beyond for the treatment of myeloma, with respective combinations also emerging as valid choices for all stages of the disease....

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is doi.org built with?


Doi.org utilizes MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

journal, treatment, agents, issue, myeloma, access, subscribe, alerts, authors, abstract, current, log, register, logo, articles, issues, therapies, buy, recent, evidence, undergoing, drugs, thalidomide, lenalidomide, bortezomib, disease, protocols, based, include, inhibitors, choices, text, subscribers, request, browse, content, submit, service, privacy, policy, secondary, advanced, search, info, previous, hematopoietic, stem, cell, transplantation, edited,

Topics {✒️}

transplant-based treatment protocols journal authors submit full text access /ii trial evaluation maximizing antitumor efficacy minimizing overlapping toxicities gene expression profiling artificial intelligence training agents undergoing assessment histone deacetylase inhibitors etoc alerts service request 800-638-3030 register subscribe individual subscribers log journal tables valid choices current evidence issue increasingly based website subscribe journal hsp90 inhibitors center submit effective agents line agents recent years trials leading recent findings proteasome inhibitor combination regimens optimal sequencing preclinical evidence improved outcomes future developments standard options respective combinations email inbox rights reserved data mining immunomodulatory drugs summary  thalidomide myeloma hayden authors content protocols treatment agents log subscribers text

Questions {❓}

  • Not a Subscriber?

External Links {🔗}(57)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

4.75s.